Abstract
Background: Pancreatic cancer is a difficult malignancy to manage with little improvement in mortality rates over time. Local control remains a challenge. The objective of this review is to discuss patient selection and technical considerations for the safe utilization of stereotactic body radiotherapy (SBRT).
Methods: An online search was completed to review available data. The current literature examining the use and delivery of SBRT for pancreatic cancer was reviewed and summarized. Patient selection criteria, technical considerations, and the implementation of SBRT are described.
Results: Studies thus far have shown promising outcomes for SBRT in terms of potential for conversion from borderline or unresectable to resectable disease as well as the feasibility of delivering SBRT safely.
Conclusion: SBRT represents an emerging treatment option for patients to improve local control through delivery of ablative, high-dose radiation while reducing radiation treatment time as compared to conventionally fractionated chemoradiation. Further studies are needed to explore the full potential and toxicities of SBRT in pancreatic cancer. The importance of technical considerations in this modality cannot be overstated.
Keywords: Surveillance, Epidemiology, and End Results Program (SEER), cancer, Celiac Axis (CA), Superior Mesenteric Artery (SMA), Common Hepatic Artery (CHA), chemoradiation.
Graphical Abstract
Current Cancer Therapy Reviews
Title:The Role of Stereotactic Body Radiation Therapy in Pancreatic Cancer
Volume: 14 Issue: 1
Author(s): Priscilla K. Stumpf and Karyn A. Goodman*
Affiliation:
- Radiation Oncology Department, University of Colorado Cancer Center, 1665 Aurora Court, Room 1032, Aurora, CO, 80045,United States
Keywords: Surveillance, Epidemiology, and End Results Program (SEER), cancer, Celiac Axis (CA), Superior Mesenteric Artery (SMA), Common Hepatic Artery (CHA), chemoradiation.
Abstract: Background: Pancreatic cancer is a difficult malignancy to manage with little improvement in mortality rates over time. Local control remains a challenge. The objective of this review is to discuss patient selection and technical considerations for the safe utilization of stereotactic body radiotherapy (SBRT).
Methods: An online search was completed to review available data. The current literature examining the use and delivery of SBRT for pancreatic cancer was reviewed and summarized. Patient selection criteria, technical considerations, and the implementation of SBRT are described.
Results: Studies thus far have shown promising outcomes for SBRT in terms of potential for conversion from borderline or unresectable to resectable disease as well as the feasibility of delivering SBRT safely.
Conclusion: SBRT represents an emerging treatment option for patients to improve local control through delivery of ablative, high-dose radiation while reducing radiation treatment time as compared to conventionally fractionated chemoradiation. Further studies are needed to explore the full potential and toxicities of SBRT in pancreatic cancer. The importance of technical considerations in this modality cannot be overstated.
Export Options
About this article
Cite this article as:
Stumpf K. Priscilla and Goodman A. Karyn *, The Role of Stereotactic Body Radiation Therapy in Pancreatic Cancer, Current Cancer Therapy Reviews 2018; 14 (1) . https://dx.doi.org/10.2174/1573394714666180119122511
DOI https://dx.doi.org/10.2174/1573394714666180119122511 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PAF Receptor and Tumor Growth
Current Drug Targets Autophagy Regulators as Potential Cancer Therapeutic agents: A Review
Current Topics in Medicinal Chemistry Ameliorative Effect of α-Tocopherol and Selenium on Effects of Malathion on Plasmatic Biochemical Indices and Lesions in the Liver of Rats
Current Pharmaceutical Analysis Advances in Immunotherapy of Chronic Myeloid Leukemia CML
Current Cancer Drug Targets Systems Biology Approaches and Metabolomics for Understanding Japanese Traditional Kampo Medicine
Current Pharmacogenomics and Personalized Medicine Characterization of the Lymphotropic Amplicons-6 and Tamplicon-7 Vectors Derived from HHV-6 and HHV-7
Current Gene Therapy Ultrashort Echo Time Spectroscopic Imaging: Magnetic Resonance Assessment of Short-T2 Tissues in the Musculoskeletal System
Recent Patents on Medical Imaging Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy Disseminated Intravascular Coagulation in Leukemia and Sepsis
Vascular Disease Prevention (Discontinued) Molecular Imaging of Breast Cancer: Role of RGD Peptides
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 13
Protein & Peptide Letters Oncologic Imaging End-Points for the Assessment of Therapy Response
Recent Patents on Anti-Cancer Drug Discovery A Novel Therapeutic Approach in Acute Promyelocytic Leukemia with All-trans retinoic Acid and Cyclin-dependent Kinase Inhibitors
Clinical Cancer Drugs Antitubulinic effect of New Fluorazone Derivatives on Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum
Current Topics in Medicinal Chemistry Activity Based Probes for Proteases: Applications to Biomarker Discovery,Molecular Imaging and Drug Screening
Current Pharmaceutical Design GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?
Current Topics in Medicinal Chemistry HLA Class I Expression, Tumor Escape and Cancer Progression
Current Cancer Therapy Reviews Application of Baculovirus-Insect Cell Expression System for Human Therapy
Current Pharmaceutical Biotechnology